483 AstraZeneca Pharmaceuticals LP May 2017

483 AstraZeneca Pharmaceuticals LP May 2017

Arie Menachem FDA, Anastasia Shields FDA, Jennifer Swisher FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Frederick, MD, United States facility and issued inspectional observations (via FDA 483) on 23 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 23 May 2017
  • Location: Frederick, United States
  • FEI: 3002617771
Add To Cart